UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000011965
Receipt No. R000013960
Official scientific title of the study Far-Infrared Therapy Treatment will be to Improve Unassisted Patency of Arteriovenous Fistula in Hemodialysis Patients
Date of disclosure of the study information 2013/10/13
Last modified on 2016/12/09 (Ver. 3)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Far-Infrared Therapy Treatment will be to Improve Unassisted Patency of Arteriovenous Fistula in Hemodialysis Patients
Title of the study (Brief title) Far-Infrared Therapy will be to Improve Unassisted Patency of AVF in HD Patients
Region
Japan

Condition
Condition hemodialysis patients
Classification by specialty
Nephrology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 Efficacy of Far-infrared Therapy unassisted patency of arteriovenous fistula in Hemodialysis Patients
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes secondary patency of AVF
Key secondary outcomes

Base
Study type

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Historical
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Treatment
Type of intervention
Device,equipment
Interventions/Control_1 Far-Infrared Therapy for Patency of Arteriovenous Fistula
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
100 years-old >
Gender Male and Female
Key inclusion criteria hemodialysis patients who will be continued for over 12 months
Key exclusion criteria skin disease patients
blood clotting defect patients
Target sample size 16

Research contact person
Name of lead principal investigator Yasuhiko Tomino
Organization Juntendo University
Division name Nephrology
Address 3-1-1Hongo,Bunkyo-ku,Tokyo
TEL 03-5802-1165
Email yasu@juntendo.ac.jp

Public contact
Name of contact person Hiroaki Io
Organization Juntendo University
Division name Nephrology
Address 3-1-1Hongo,Bunkyo-ku,Tokyo
TEL 03-5802-1065
Homepage URL
Email hiroaki@juntendo.ac.jp

Sponsor
Institute Juntendo University
Institute
Department

Funding Source
Organization none
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2013 Year 10 Month 13 Day

Progress
Recruitment status Completed
Date of protocol fixation
2013 Year 09 Month 20 Day
Anticipated trial start date
2013 Year 10 Month 13 Day
Last follow-up date
2015 Year 12 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2013 Year 10 Month 04 Day
Last modified on
2016 Year 12 Month 09 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000013960